Spinal implant and Mind-Controlled rehab may restore arm movement after stroke

NCT ID NCT07686822

Not yet recruiting Disease control Sponsor: Zhejiang Provincial People's Hospital Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether combining spinal cord stimulation with brain-computer interface training can improve arm function in people who had a stroke more than six months ago. Participants will either receive both treatments or the brain-computer training alone. The goal is to see if the combination leads to better movement and daily use of the affected arm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: spinal cord stimulation device and motor imagery brain-computer interface training
What this could lead to: If successful, this combination approach could offer a new way to restore arm movement in people who have had a stroke, even years later.
What could go wrong: This is an early-stage, single-center study with only 66 participants, so results may not apply broadly. The spinal cord stimulation requires surgery, which carries risks like infection or device problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC STROKE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, 310014, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.